Icecure Medical (ICCM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Icecure Medical (ICCM) last issued guidance on January 10, 2024 for fiscal year 2023. The company guided revenue in the range of $3.2M - $3.2M for the period.
Compared to prior guidance, Icecure Medical raised its revenue forecast from a prior range of $3.1M - $3.1M.
Icecure Medical has issued 2 guidance updates between February 9, 2023 and January 10, 2024. During this period, the company raised its outlook 1 time, reflecting management's growing confidence in business performance.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | FY '22 | FY '21 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||||
| Estimate | $-1.29 | $-1.20 | $-1.20 | $-1.50 | $-3.00 | — |
| Actual | $-1.37 | $-1.80 | $-1.80 | $-1.80 | $-13.80 | $-10.50 |
| Surprise | -6.20% | -50.0% | -50.0% | -20.0% | -360.0% | — |
| Revenue | ||||||
| Estimate | $1.7M | $1.5M | $1.3M | $714000 | $1.0M | — |
| Actual | $889000 | $911000 | $1.3M | $850000 | $3.1M | $4.1M |
| Surprise | -46.7% | -38.4% | -1.62% | +19.1% | +208.5% | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.82 | $-0.87 |
| Revenue | ||
| Consensus | $2.0M | $2.4M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-1.37 | $-1.29 | -6.20 % |
| Q1 | May 12, 2026 | $-1.80 | $-1.20 | -50.0 % |
| Q4 | Mar 17, 2026 | $-1.80 | $-1.20 | -50.0 % |
| Q3 | Nov 19, 2025 | $-1.80 | $-1.50 | -20.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $889.00K | $1.67M | -46.7 % |
| Q1 | May 12, 2026 | $911.00K | $1.48M | -38.4 % |
| Q4 | Mar 17, 2026 | $1.28M | $1.30M | -1.62 % |
| Q3 | Nov 19, 2025 | $850.00K | $714.00K | 19.1 % |